A Review of the International Early Recommendations for Departments Organization and Cancer Management Priorities During the Global COVID-19 Pandemic: Applicability in Low- and Middle-income Countries

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165,000 deaths, including two-third in Europe. In this context, Oncology Departments of the affected countries had to adapt quickly their health system care and establish new organizations and priorities. Thus, numerous recommendations and therapeutic options have been reported to optimize therapy delivery to patients with chronic disease and cancer. Obviously, while these cancer care recommendations are immediately applicable in Europe, they may not be applicable in certain emerging and low- and middle-income countries (LMICs). In this review, we aimed to summarize these international guidelines in accordance with cancer types, making a synthesis for daily practice to protect patients, staff and tailor anti-cancer therapy delivery taking into account patients/tumour criteria and tools availability. Thus, we will discuss their applicability in the LMICs with different organizations, limited means and different constraints.

Citing Articles

Collateral effects of the COVID-19 pandemic on endocrine treatments for breast and prostate cancer in the UK: a cohort study.

Barclay N, Catala M, Jodicke A, Prieto-Alhambra D, Newby D, Delmestri A Ther Adv Med Oncol. 2024; 16:17588359241253115.

PMID: 38832300 PMC: 11146008. DOI: 10.1177/17588359241253115.

Time interval between breast cancer diagnosis and surgery is associated with disease outcome.

Zhu S, Li S, Huang J, Fei X, Shen K, Chen X Sci Rep. 2023; 13(1):12091.

PMID: 37495705 PMC: 10372101. DOI: 10.1038/s41598-023-39259-3.

Biological effects of COVID-19 on lung cancer: Can we drive our decisions.

Aramini B, Masciale V, Samarelli A, Tonelli R, Cerri S, Clini E Front Oncol. 2022; 12:1029830.

PMID: 36300087 PMC: 9589049. DOI: 10.3389/fonc.2022.1029830.

Twelve-month observational study of children with cancer in 41 countries during the COVID-19 pandemic.

BMJ Glob Health. 2022; 7(10).

PMID: 36261229 PMC: 9581782. DOI: 10.1136/bmjgh-2022-008797.

Impact of COVID-19 on the Organization of Cancer Care in Belgium: Lessons Learned for the (Post-)Pandemic Future.

Kenis I, Theys S, Hermie E, Foulon V, Van Hecke A Int J Environ Res Public Health. 2022; 19(19).

PMID: 36231756 PMC: 9566094. DOI: 10.3390/ijerph191912456.

References

Spolverato G, Capelli G, Restivo A, Bao Q, Pucciarelli S, Pawlik T . The management of surgical patients during the coronavirus disease 2019 (COVID-19) pandemic. Surgery. 2020; 168(1):4-10. PMC: 7252049. DOI: 10.1016/j.surg.2020.04.036. View

Meulendijks D, Dewit L, Tomasoa N, van Tinteren H, Beijnen J, Schellens J . Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option. Br J Cancer. 2014; 111(9):1726-33. PMC: 4453727. DOI: 10.1038/bjc.2014.467. View

Coles C, Aristei C, Bliss J, Boersma L, Brunt A, Chatterjee S . International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic. Clin Oncol (R Coll Radiol). 2020; 32(5):279-281. PMC: 7270774. DOI: 10.1016/j.clon.2020.03.006. View

Guckenberger M, Belka C, Bezjak A, Bradley J, Daly M, Deruysscher D . Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement. Radiother Oncol. 2020; 146:223-229. PMC: 7252074. DOI: 10.1016/j.radonc.2020.04.001. View

Rahimi F, Talebi Bezmin Abadi A . Practical Strategies Against the Novel Coronavirus and COVID-19-the Imminent Global Threat. Arch Med Res. 2020; 51(3):280-281. PMC: 7270650. DOI: 10.1016/j.arcmed.2020.03.005. View

Tuech J, Gangloff A, Di Fiore F, Michel P, Brigand C, Slim K . Strategy for the practice of digestive and oncological surgery during the Covid-19 epidemic. J Visc Surg. 2020; 157(3S1):S7-S12. PMC: 7269902. DOI: 10.1016/j.jviscsurg.2020.03.008. View

Erlandsson J, Holm T, Pettersson D, Berglund A, Cedermark B, Radu C . Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017; 18(3):336-346. DOI: 10.1016/S1470-2045(17)30086-4. View

Akladios C, Azais H, Ballester M, Bendifallah S, Bolze P, Bourdel N . Recommendations for the surgical management of gynecological cancers during the COVID-19 pandemic - FRANCOGYN group for the CNGOF. J Gynecol Obstet Hum Reprod. 2020; 49(6):101729. PMC: 7118621. DOI: 10.1016/j.jogoh.2020.101729. View

Braunstein L, Gillespie E, Hong L, Xu A, Bakhoum S, Cuaron J . Breast Radiation Therapy Under COVID-19 Pandemic Resource Constraints-Approaches to Defer or Shorten Treatment From a Comprehensive Cancer Center in the United States. Adv Radiat Oncol. 2020; 5(4):582-588. PMC: 7118660. DOI: 10.1016/j.adro.2020.03.013. View

10.

Ohannessian R, Duong T, Odone A . Global Telemedicine Implementation and Integration Within Health Systems to Fight the COVID-19 Pandemic: A Call to Action. JMIR Public Health Surveill. 2020; 6(2):e18810. PMC: 7124951. DOI: 10.2196/18810. View

11.

Filippi A, Russi E, Magrini S, Corvo R . Letter from Italy: First practical indications for radiation therapy departments during COVID-19 outbreak. Int J Radiat Oncol Biol Phys. 2020; 107(3):597-599. PMC: 7141469. DOI: 10.1016/j.ijrobp.2020.03.007. View

12.

Al-Shamsi H, Alhazzani W, Alhuraiji A, Coomes E, Chemaly R, Almuhanna M . A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist. 2020; 25(6):e936-e945. PMC: 7288661. DOI: 10.1634/theoncologist.2020-0213. View

13.

Rullier E, Rouanet P, Tuech J, Valverde A, Lelong B, Rivoire M . Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial. Lancet. 2017; 390(10093):469-479. DOI: 10.1016/S0140-6736(17)31056-5. View

14.

Grellety T, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R . [SARS-CoV-2/COVID 19 Infection and Solid Cancers: Synthesis of Recommendations for Health Professionals]. Bull Cancer. 2020; 107(4):400-402. PMC: 7195419. DOI: 10.1016/j.bulcan.2020.03.001. View

15.

. [Expert recommendations on the management of patients with advanced non-small cell lung cancer during epidemic of coronavirus disease 2019 (Trial version)]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43(4):297-301. DOI: 10.3760/cma.j.cn112147-20200221-00138. View

16.

Mejean A, Roupret M, Rozet F, Bensalah K, Murez T, Game X . [Recommendations CCAFU on the management of cancers of the urogenital system during an epidemic with Coronavirus COVID-19]. Prog Urol. 2020; 30(5):221-231. PMC: 7146722. DOI: 10.1016/j.purol.2020.03.009. View

17.

Zaorsky N, Yu J, McBride S, Dess R, Jackson W, Mahal B . Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19. Adv Radiat Oncol. 2020; 5(4):659-665. PMC: 7118610. DOI: 10.1016/j.adro.2020.03.010. View

18.

Di Saverio S, Pata F, Gallo G, Carrano F, Scorza A, Sileri P . Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience. Colorectal Dis. 2020; 22(6):625-634. DOI: 10.1111/codi.15056. View

19.

You B, Ravaud A, Canivet A, Ganem G, Giraud P, Guimbaud R . The official French guidelines to protect patients with cancer against SARS-CoV-2 infection. Lancet Oncol. 2020; 21(5):619-621. PMC: 7118635. DOI: 10.1016/S1470-2045(20)30204-7. View

20.

Cortiula F, Pettke A, Bartoletti M, Puglisi F, Helleday T . Managing COVID-19 in the oncology clinic and avoiding the distraction effect. Ann Oncol. 2020; 31(5):553-555. PMC: 7174827. DOI: 10.1016/j.annonc.2020.03.286. View